This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Metabolic & Atherosclerosis Research Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Evan A Stein
Introduction
Evan A Stein is a notable inventor based in the United States. He has made significant contributions to the field of medicine, particularly in the treatment of cholesterol-related disorders. Although he currently holds no patents, his work has the potential to impact many lives.
Latest Patents
Evan A Stein's latest patents include innovative methods for treating homozygous familial hypercholesterolemia. This invention focuses on using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9) to effectively treat this condition. Additionally, he has developed methods for treating or preventing cholesterol-related disorders, such as hypercholesterolemia, hyperlipidemia, or dyslipidemia, also utilizing antibodies against PCSK9. These formulations and the methods of producing them are crucial advancements in the field.
Career Highlights
Throughout his career, Evan A Stein has dedicated himself to researching and developing solutions for cholesterol-related health issues. His work is characterized by a commitment to improving patient outcomes through innovative medical treatments.
Collaborations
Evan has collaborated with esteemed colleagues, including Joyce Chi Chan and John P Gibbs. Their combined expertise has contributed to the advancement of research in cholesterol treatment.
Conclusion
Evan A Stein's contributions to the field of medicine, particularly in cholesterol-related disorders, showcase his innovative spirit and dedication to improving health outcomes. His ongoing research and potential future patents may lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile